Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Our personalized healthcare strategy aims at providing medicines that enable tangible improvements in the health, quality of life and survival of patients.

31 medicines developed by Roche are included in the WHO Model Lists of Essential Medicines. Twenty-five of these are patent-free and include life-saving antibiotics, anti-malarials and chemotherapy1,2. We have been at the forefront of cancer research and treatment for over 50 years, with medicines for breast, skin, colon, ovarian, lung and numerous other cancers.

Roche Bangladesh Limited is an affiliate of Roche group which was founded in 1896 in Basel, Switzerland. Since 1998, we are bringing latest treatment solutions for patients, suffering from cancer, anaemia, transplant, viral and immunological diseases in Bangladesh.

We have extended our cooperation with our local business partner by Technology transfers, knowledge sharing and capability development. Roche Bangladesh also supported local hospitals to build center of excellence for HER2, a biomarker testing for breast cancer. Every year more than Ten thousand patients are being treated with Roche innovative medicines in Bangladesh.

In 2020 Roche invested 12.2 billion Swiss Francs3 in Research and Development because, Innovation: It's in our DNA.


1. Developing essential medicines. Roche products on the WHO Model List of Essential Medicines (2017). [Internet; cited 2018, November 08]. Retrieved from

2. WHO Model List of Essential Medicines, 20th List, (2017, March, Amended August). [Internet; cited 2018, November 08]. Retrieved from

3. Annual Report 2020. [Internet; cited 2021, November]. Retrieved from